Cargando…
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
More than one year since its emergence, corona virus disease 2019 (COVID-19) is still looming large with a paucity of treatment options. To add to this burden, a sizeable subset of patients who have recovered from acute COVID-19 infection have reported lingering symptoms, leading to significant disa...
Autores principales: | Ramakrishnan, Rakhee K., Kashour, Tarek, Hamid, Qutayba, Halwani, Rabih, Tleyjeh, Imad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278217/ https://www.ncbi.nlm.nih.gov/pubmed/34276671 http://dx.doi.org/10.3389/fimmu.2021.686029 |
Ejemplares similares
-
Persistent COVID-19 symptoms at least one month after diagnosis: A national survey
por: Tleyjeh, Imad M., et al.
Publicado: (2022) -
It is time to drop hydroxychloroquine from our COVID-19 armamentarium
por: Kashour, Tarek, et al.
Publicado: (2020) -
Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up
por: Tleyjeh, Imad M., et al.
Publicado: (2021) -
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City
por: Tleyjeh, Imad M., et al.
Publicado: (2021) -
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
por: Kashour, Tarek, et al.
Publicado: (2021)